NEFL and Alzheimer disease: Current data show that in particular the Aβ42/40 ratio and NFL measured from blood using new technologies show a high degree of specificity and sensitivity to detect AD in individual years before onset of symptoms and correlate with CSF and imaging changes over the disease course.